Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...

Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...

Michael Olunga shared a telling post after Harambee Stars were torn apart by Senegal on Tuesday evening Harambee Stars suffered one of their biggest defeats in history as the Lions of Teranga put ...

Benni McCarthy has come under scrutiny for his decision to exclude the Kenyan national team captain from the latest set of international fixtures. The South African has been in charge of the Harambee ...